We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Medicare Act Reforms Hatch-Waxman Procedures

Law360 (January 2, 2004, 12:00 AM EST) -- The Medicare Prescription Drug, Improvement, and Modernization Act signed into law by President George W. Bush last month modifies the approval process for generic drugs in several important ways, intellectual property attorneys say.

In addition, the new act codifies many of the current regulatory practices at the Food and Drug Administration, they say.

“Only six of 680 pages directly affect intellectual property issues, but the changes are likely to affect litigation arising out of ANDA filings as well as the marketing of new generics under the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.